Morgan Stanley Maintains Equal-Weight on Lemonade, Lowers Price Target to $56
Morgan Stanley analyst Bob Huang maintains Lemonade (NYSE:LMND) with a Equal-Weight and lowers the price target from $65 to $56.
Read original at benzingaStocks · News reference
Lemonade reports 79% revenue growth in Q2, narrows EBITDA losses, and raises FY26 guidance as premium growth accelerates.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Morgan Stanley analyst Bob Huang maintains Lemonade (NYSE:LMND) with a Equal-Weight and lowers the price target from $65 to $56.
Read original at benzingaLemonade, an AI-powered insurance claims processor, significantly improved its financial performance in Q2 2026 with a 79% revenue surge to $294 million and a 54% reduction in adjusted EBITDA losses to $19 million. The company projects its first-ever positive adjusted EBITDA of $8 million in Q4 2026, driven by 32.4% growth in in-force premiums and a best-ever 5% loss adjustment expense ratio. Management expects full-year profitability in 2027.
Read original at the-motley-foolRoot Insurance has achieved profitability and a Superscore of 74 out of 100, driven by its AI-powered telematics pricing model and embedded partnerships with platforms like Carvana. Despite strong operational metrics including a 92% net combined ratio and 36 billion miles of driving data, the stock faces headwinds from intense competition, customer friction, and valuation sensitivity. The company must balance profitability with market expansion to sustain growth and avoid being outpaced by competitors like Lemonade.
Read original at the-motley-fool